Skip to content
Screener

10x Genomics, Inc. TXG China — Revenue

Other geography segments

United States
$103.49M

Similar metrics at other companies

Credo Technology Group Holding Ltd logo
CRDOChina — Revenue
$1.8M-94.3%
Organon logo
OGNChina — Revenue
$194M-4.9%
Alpha and Omega Semiconductor logo
AOSLCHINA — Revenue
$4.6M-75.4%
Silicon Laboratories logo
SLABChina — Revenue
$67.32M+14.6%
Belden logo
BDCChina — Revenue
$24.81M+7.7%
InterDigital logo
IDCCChina — Revenue
$77.33M-18.5%

Other financials

Income statement

See full
Revenue$151.0M-12.6%
Gross profit$112.5M-10.1%
Operating income-$19.6M-165%
Net income-$17.9M-152%
EPS (diluted)-$0.14-150%

Balance sheet

See full
Cash & equivalents$502.5M+26.4%
Total debt$78.8M-9.2%
Total equity$825.5M+6.8%
Total assets$1.0B+5.1%

Cash flow

See full
Operating cash flow$17.0M-4.1%
CapEx$1.6M+0.6%
Free cash flow$15.4M-4.6%

Valuation

See full
Market cap$5.79B+271%
Enterprise value$5.37B+330%
P/S9.4×+7.0×

Profitability

See full
Gross margin70%+0.5pp
Operating margin-14.3%-1.1pp
Net margin-12.2%-0.8pp
FCF margin19.7%+10.9pp

Returns & leverage

See full
Return on equity-9.4%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.7×-0.1×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054491
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Americas (excluding United States)2,9172,6676,3236,419
Total Americas85,026106,158165,125196,728
Europe, Middle East and Africa39,97234,73476,82466,629
Asia-Pacific
China14,96823,17030,80540,053
Asia-Pacific (excluding China)11,0708,84629,12524,381
Total Asia-Pacific26,03832,01659,93064,434
Total revenue$151,036$172,908$301,879$327,791

Item 1. Financial Statements (Unaudited)

FAQ

What is 10x Genomics, Inc.'s china — revenue?
10x Genomics, Inc. (TXG) reported china — revenue of $14.97M in Q2 2026.
How has 10x Genomics, Inc.'s china — revenue changed year-over-year?
10x Genomics, Inc.'s china — revenue decreased by 35.4% year-over-year, from $23.17M to $14.97M.
What is the long-term trend for 10x Genomics, Inc.'s china — revenue?
Over 4 years (2021 to 2025), 10x Genomics, Inc.'s china — revenue has grown at a -2.5% compound annual growth rate (CAGR), from $77.9M to $70.26M.
What does china — revenue mean?
This metric represents the total gross sales generated from products and services sold within the China geographic region. It serves as a key indicator of the company's market penetration, competitive positioning, and demand for life science technology solutions in this specific territory. Tracking this figure helps investors assess regional growth trends and the impact of local regulatory or economic environments on the company's international performance.

Ask your AI about 10x Genomics, Inc.'s china — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude